Antibodies from the serum of patients with the acquired immune deficiency syndrome (AIDS)
or with the AIDS-related complex and from the serum of seropositive healthy homosexuals …

In this study, two glycoproteins (gp160 and gp120) that are encoded by human T-cell
lymphoma virus type III (HTLV-III) were the antigens most consistently recognized by …

In a study performed to determine which regions of the human T-cell lymphotrophic virus
type III (HTLV-III) may represent vaccine candidates to prevent the acquired immune …

Cross-reactive antigens of molecular size of 61,000 to 68,000 daltons are found on the
surface of human cells infected by human T-cell leukemia-lymphoma virus (HTLV). They are …

The envelope (env) and structural (gag) gene products of human T-cell leukemia
(lymphotropic) virus type III were identified by immunoaffinity chromatography …

Human T-lymphotropic virus type III (HTLV-III) or lymphadenopathy-associated virus (LAV) is
tropic for human T cells with the helper-inducer phenotype, as defined by reactivity with …

In cats, infection with T-lymphotropic retroviruses can cause T-cell proliferation and leukemia
or T-cell depletion and immunosuppression. In humans, some highly T4 tropic retroviruses …

A newly identified protein from HTLV-III/LAV, the virus implicated as the etiologic agent of the
acquired immune deficiency syndrome, was studied. This protein, which has a molecular …

Peripheral blood leukocytes and saliva from 20 individuals, including four with the acquired
immune deficiency syndrome (AIDS), ten with AIDS-related complex (ARC), and six healthy …

Radiolabeled amino acid sequencing was used to characterize gp41, an antigen of HTLV-
III/LAV, the virus believed to be the etiological agent of the acquired immune deficiency …